Mining RNA sequencing data to improve cancer research
ARCHS4: Massive Mining of Publicly Available RNA Sequencing Data
This study is working on making cancer-related RNA sequencing data easier to access and use, so that researchers of all experience levels can better analyze and understand important genetic information.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10909127 on NIH RePORTER |
What this research studies
This research focuses on enhancing the accessibility and usability of RNA sequencing data related to cancer. It aims to process and standardize data from various studies, making it easier for researchers to analyze and integrate findings. By developing a resource called ARCHS4, the project will provide a user-friendly web interface for accessing processed RNA-seq data, enabling both experienced and novice researchers to conduct retrospective analyses. Additionally, the research will explore advanced techniques like Deep Learning to transform transcriptomics data and identify important genetic sequences.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include cancer patients whose data can be analyzed to identify new therapeutic targets or biomarkers.
Not a fit: Patients with conditions unrelated to cancer or those not involved in RNA sequencing studies may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the ability of cancer researchers to utilize existing RNA sequencing data, leading to better insights and advancements in cancer treatment.
How similar studies have performed: Other research initiatives have successfully improved data accessibility and analysis in genomics, suggesting that this approach has the potential for significant impact.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Ma'ayan, Avi — Icahn School of Medicine at Mount Sinai
- Study coordinator: Ma'ayan, Avi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.